Mucosta eye drops – dry eye treatment from Japan

General information about Japanese Mucosta eye drops – dry eye treatment

One last box available, no prospect of supply.

Package details: 56 bottles of 0.35 ml each

Manufacturer: Otsuka Pharmaceutical, Japan

Active ingredient: rebapimide

Medical effect: Mucosta ophthalmologic suspension has the following effects:

• improving the production of tears,
• stabilizing tear film,
• improving corneal epithelium damage,
• treating dry eye syndrome.

Contraindications and precautions:

Do not use in children, pregnant or breastfeeding women. Do not use with contact lenses. If an allergic reaction occurs, stop using the product and consult with your doctor. 

Dosage and Administration of Mucosta eye drops – dry eye treatment from Japan

Use 1 drop a time 4 times a day. Hold the lower part of the container and flick toward the widened part to disperse the medicine before instilling. After instillation, close the eyes with hands for 1 minute, then open the eyes and wipe the excess of the suspension.

How effective is Japanese Mucosta eye drops for dry eye treatment?

Mucosta ophthalmic suspension was created by Otsuka Pharmaceutical, Co., Ltd, Tokyo, Japan, and prescribed by ophthalmologists since 2012.  It contains 2% of rebamipide which stimulates mucous secretion. Mucosta eye drops increase the tear film layer’s stability. Nowadays, it’s one of the most popular ways of treatment the dry eye syndrome in Japan (M. Kawashima, M. Yamada et al. A clinic-based survey of clinical characteristics and practice pattern of dry eye in Japan. Advances in Therapy. 2017; 34: 732–743).